Imatinib and nilotinib are equally successful in achieving therapy-free remission

Abstract

This research paper explore the methodology and findings associated with Blood Cancer Journal. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now